These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 944895)

  • 21. The association of HLA antigens A3, B7, and DW2 with 330 multiple sclerosis patients in the United States.
    Opelz G; Terasaki P; Myers L; Ellison G; Ebers G; Zabriskie J; Weiner H; Kempe H; Sibley W
    Tissue Antigens; 1977 Jan; 9(1):54-8. PubMed ID: 850918
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HLA B27 and ankylosing spondylitis in the Israeli population.
    Brautbar C; Porat S; Nelken D; Gabriel KR; Cohen T
    J Rheumatol Suppl; 1977; 3():24-32. PubMed ID: 266593
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic association of multiple sclerosis and HL-A determinants.
    Alter M; Harshe M; Anderson VE; Emme L; Yunis EJ
    Neurology; 1976 Jan; 26(1):31-6. PubMed ID: 54888
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Distribution of histocompatibility antigens among multiple sclerosis patients in the Armenian population].
    Darbinian VZh; Nersisian VM; Martirosian IG
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1981; 81(7):1038-43. PubMed ID: 6457477
    [No Abstract]   [Full Text] [Related]  

  • 25. A review of the etiology of multiple sclerosis.
    Vella V
    Ital J Neurol Sci; 1984 Dec; 5(4):347-56. PubMed ID: 6099345
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Histocompatibility antigens in multiple sclerosis patients].
    Khondkarian OA; Tananov AT; Zavalishin IA; Nevskaia OM; Kut'ina RM
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1981; 81(2):7-10. PubMed ID: 7234266
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HLA in multiple sclerosis. Relationship to measles antibody, mitogen responsiveness and clinical course.
    Paty DW; Dossetor JB; Stiller CR; Cousin HK; Marchuk L; Furesz J; Boucher DW
    J Neurol Sci; 1977 Jul; 32(3):371-9. PubMed ID: 886362
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multiple sclerosis in the Orkney and Shetland Islands. III: Histocompatibility determinants.
    Poskanzer DC; Terasaki PI; Prenney LB; Sheridan JL; Park MS
    J Epidemiol Community Health; 1980 Dec; 34(4):253-7. PubMed ID: 6972433
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Histocompatibility types and viral antibodies.
    Lehrich JR; Arnason BG
    Arch Neurol; 1976 Jun; 33(6):404-5. PubMed ID: 180933
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The major histocompatibility system, HLA, and multiple sclerosis.
    Jersild C
    Acta Neurol Scand Suppl; 1977; 63():17-21. PubMed ID: 66848
    [No Abstract]   [Full Text] [Related]  

  • 31. [Multiple sclerosis and the histocompatibility system].
    Khondkarian OA; Tananov AT; Zavalishin IA; Nevskaia OM
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1982; 82(2):167-71. PubMed ID: 6176089
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HLA antigen in Jewish patients with juvenile diabetes mellitus [proceedings].
    Gazit E; Sartani A; Ravid M
    Diabete Metab; 1976 Sep; 2(3):161. PubMed ID: 1010137
    [No Abstract]   [Full Text] [Related]  

  • 33. Genetical aspects of multiple sclerosis with special regard to histocompatibility determinants.
    Kuwert EK
    Acta Neurol Scand Suppl; 1977; 63():23-42. PubMed ID: 66850
    [No Abstract]   [Full Text] [Related]  

  • 34. HLA antigen in Jewish patients with juvenile diabetes mellitus.
    Gazit E; Sartani A; Mizrachi Y; Ravid M
    Diabete Metab; 1977 Mar; 3(1):55-8. PubMed ID: 858444
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multiple sclerosis in immigrant and native populations of Israel.
    Leibowitz U; Kahana E; Alter M
    Lancet; 1969 Dec; 2(7634):1323-5. PubMed ID: 4188092
    [No Abstract]   [Full Text] [Related]  

  • 36. HLA antigens and uveitis.
    Ohno S; Kimura SJ; O'Connor GR; Char DH
    Br J Ophthalmol; 1977 Jan; 61(1):62-4. PubMed ID: 556942
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunogenetic studies of multiple sclerosis patients in Caithness County, Scotland.
    Robertson P; Ward P; Brostoff J; Pack S; Festenstein H; Sacks J; Rosenberg RA; Peters E; Stenning P; Zabriskie JB
    Neuropathol Appl Neurobiol; 1980; 6(4):299-305. PubMed ID: 7413014
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [HLA-DRW antigens and multiple sclerosis].
    De Moerloose PH; Jeannet M; Martins-da-Silva B; Werner-Favre C; Rohr J; Gauthier G
    Schweiz Arch Neurol Neurochir Psychiatr; 1978; 123(1):51-61. PubMed ID: 83671
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Migration and risk of multiple sclerosis.
    Alter M; Kahana E; Loewenson R
    Neurology; 1978 Nov; 28(11):1089-93. PubMed ID: 568726
    [No Abstract]   [Full Text] [Related]  

  • 40. Multiple sclerosis: genetic versus environmental aetiology: epidemiology in Israel updated.
    Kahana E; Zilber N; Abramson JH; Biton V; Leibowitz Y; Abramsky O
    J Neurol; 1994 Mar; 241(5):341-6. PubMed ID: 8006689
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.